Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ROIV is expected to report earnings to rise 89.82% to -32 cents per share on February 16
Q4'25
Est.
$-0.32
Q3'25
Beat
by $0.15
Q2'25
Missed
by $0.08
Q1'25
Missed
by $0.03
Q4'24
Beat
by $0.48
The last earnings report on November 10 showed earnings per share of -17 cents, beating the estimate of -31 cents. With 3.46M shares outstanding, the current market capitalization sits at 14.83B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ROIV showed earnings on November 10, 2025. You can read more about the earnings report here.